The global automated sample preparation market is expected to expand at a 10.10% CAGR from 2025 to 2031, driven by pharmaceutical R&D investments, need for reproducibility, and AI/ML adoption. However, high initial costs and integration challenges with legacy systems remain significant barriers, particularly for smaller laboratories and SMEs.
Mettler-Toledo International (MTD)
Common Stock · Currency in USD · XNYS
Mettler-Toledo supplies weighing and precision instruments to customers in the life sciences (around 55% of sales), industrial (around 40%), and food retail (around 5%) industries. Its products include laboratory and retail scales, pipettes, pH meters, thermal analysis equipment, titrators, metal detectors, and X-ray analyzers. Mettler leads the market for weighing instrumentation and controls more than 50% of the market for lab balances. The business is geographically diversified, with the Americas accounting for about 37% of sales, Europe about 27%, China about 16% and the rest of the world about 20%.
Company Info
SIC3826
Composite FIGIBBG000BZCKH3
CIK0001037646
IPONov 14, 1997
Sectorlaboratory analytical instruments
Highlights
Market Cap$25.51B
EPS$42.40
P/E Ratio29.32
Revenue$4.03B
Gross Profit$2.44B
Net Income$869.97M
Employees18,100
WSO20,248,505
Phone(614) 438-4511
Websitehttps://www.mt.com
Related Tickers
A
Agilent Technologies Inc.
$115.48 0.00%
TMO
Thermo Fisher Scientific, Inc.
$489.90 0.00%
WAT
Waters Corp
$304.24 0.00%
DHR
Danaher Corporation
$191.12 0.00%
TECH
Bio-Techne Corp.
$53.13 0.00%
RVTY
Revvity, Inc.
$88.94 0.00%
IQV
IQVIA Holdings Inc.
$173.26 0.00%
BRKR
Bruker Corporation
$36.90 0.00%
BIO
Bio-Rad Laboratories, Inc.Class A
$279.99 0.00%
RGEN
Repligen Corp
$117.78 0.00%
Analysis
Share Price Chart
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Mettler-Toledo International, comparing it to the performance of the S&P 500 index.
All prices have been adjusted for splits and dividends.
Returns By Period
Mettler-Toledo International (MTD) has returned -9.93% so far this year and 24.41% over the past 12 months. Looking at the last ten years, MTD has achieved an annualized return of 13.65%, outperforming the Benchmark (SPY), which averaged 12.23% per year.
MTD
1M-0.71%
6M-4.19%
YTD-9.93%
1Y24.41%
5Y0.60%
10Y13.65%
Benchmark (SPY)
1M-3.85%
6M-2.35%
YTD-4.36%
1Y34.06%
5Y9.80%
10Y12.23%
Monthly Returns
The table below presents the monthly returns of Mettler-Toledo International (MTD) with color gradation from worst to best to easily spot seasonal factors.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -1.83% | 0.16% | -6.34% | -0.78% | ||||||||
| 2025 | 10.27% | -5.15% | -7.44% | -9.00% | 7.58% | 2.69% | 5.35% | 5.46% | -4.84% | 15.36% | 4.82% | -5.38% |
| 2024 | -0.37% | 4.28% | 7.23% | -8.58% | 14.56% | 0.62% | 8.31% | -5.57% | 6.12% | -13.54% | -6.53% | -1.99% |
| 2023 | 5.34% | -6.59% | 7.46% | -1.91% | -11.50% | -1.00% | -4.84% | -3.14% | -9.57% | -10.68% | 10.63% | 11.31% |
| 2022 | -12.90% | -5.16% | -2.23% | -7.55% | 1.07% | -11.73% | 17.23% | -9.47% | -10.24% | 14.94% | 14.38% | -2.57% |
| 2021 | 1.13% | -5.37% | 2.56% | 12.59% | -1.35% | 5.30% | 6.45% | 4.55% | -11.18% | 8.11% | 2.02% | 11.95% |
| 2020 | -5.96% | -8.03% | -1.98% | 7.84% | 12.02% | 0.97% | 16.28% | 4.02% | -0.79% | 2.39% | 12.87% | -1.48% |
| 2019 | 14.47% | 6.28% | 5.65% | 2.21% | -3.33% | 15.71% | -11.29% | -13.45% | 7.55% | -0.07% | 1.33% | 10.00% |
| 2018 | 8.49% | -8.84% | -6.97% | -2.62% | -0.83% | 4.26% | 3.16% | -0.93% | 4.89% | -10.59% | 15.79% | -10.93% |
| 2017 | 1.11% | 11.50% | -0.23% | 7.34% | 13.29% | 0.94% | -3.36% | 4.96% | 3.20% | 8.27% | -8.21% | -1.81% |
| 2016 | 4.56% | 4.77% | -2.19% | 12.66% | -1.91% | 3.90% | -3.33% | 1.83% | 1.00% |
Performance Indicators
The charts below present risk-adjusted performance metrics for Mettler-Toledo International (MTD) and compare them to a Benchmark (SPY). These indicators evaluate an investment's returns against its associated risks.
Sharpe ratio
Sortino ratio
Omega ratio
Calmar ratio
Martin ratio
sharpe ratio
The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.
These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns.
The chart below shows the rolling Sharpe ratio of MTD compared to the benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.
Volatility Chart
The current Mettler-Toledo International volatility is 2.09%, representing the standart deviation of percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. It shows the maximum percentage drop from a peak to a trough over a specified period, indicating the risk of significant losses.
Although chart shows positive values, it represents the percentage drop from the peak, so a value of 10% means the portfolio has dropped 10% from its highest point.
Income Statement
The income statement provides a summary of a company's revenues, expenses, and profits over a specific period. It shows how much money the company earned (revenues) and how much it spent (expenses), leading to the net income or profit. This statement is crucial for understanding a company's financial performance and profitability.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Liabilities And Equity (USD) | 3.71B | 3.24B | 3.36B | 3.49B | 3.33B | 2.81B | 2.79B | 2.62B | 2.55B | 2.17B | 2.02B | 2.01B | 2.15B | 2.12B | 2.20B | 2.28B |
| Equity Attributable To Parent (USD) | -23.64M | -126.89M | -149.94M | 24.79M | 171.42M | 282.68M | 420.78M | 590.06M | 547.28M | 434.94M | 580.46M | 719.60M | 935.05M | 827.22M | 781.14M | 771.58M |
| Equity Attributable To Noncontrolling Interest (USD) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Equity (USD) | -23.64M | -126.89M | -149.94M | 24.79M | 171.42M | 282.68M | 420.78M | 590.06M | 547.28M | 434.94M | 580.46M | 719.60M | 935.05M | 827.22M | 781.14M | 771.58M |
| Other Non-current Liabilities (USD) | 449.93M | 367.43M | 435.79M | 411.39M | 428.03M | 407.37M | 378.68M | 309.33M | 352.68M | 269.26M | - | - | - | - | - | - |
| Long-term Debt (USD) | 2.09B | 1.83B | 1.89B | 1.91B | 1.58B | 1.28B | 1.24B | 985.02M | 960.17M | 875.06M | - | - | - | - | - | - |
| Noncurrent Liabilities (USD) | 2.54B | 2.20B | 2.32B | 2.32B | 2.01B | 1.69B | 1.61B | 1.29B | 1.31B | 1.14B | 842.90M | 610.63M | 653.58M | 727.50M | 812.49M | 969.29M |
| Other Current Liabilities (USD) | 731.97M | 767.82M | 810.36M | 695.16M | 637.36M | 485.27M | 413.52M | 385.28M | 351.89M | 300.46M | 316.64M | 396.89M | 294.70M | 300.90M | 301.80M | 265.72M |
| Wages (USD) | 199.52M | 184.53M | 160.31M | 200.03M | 236.27M | 179.25M | 155.40M | 152.52M | 170.16M | 140.46M | 136.41M | 136.11M | 123.49M | 119.42M | 139.94M | 138.36M |
| Accounts Payable (USD) | 266.63M | 215.84M | 210.41M | 252.54M | 272.91M | 175.80M | 185.59M | 196.64M | 167.63M | 146.59M | 142.08M | 145.90M | 145.99M | 142.36M | 168.11M | 138.11M |
| Current Liabilities (USD) | 1.20B | 1.17B | 1.18B | 1.15B | 1.15B | 840.33M | 754.51M | 734.43M | 689.67M | 587.52M | 595.13M | 678.89M | 564.19M | 562.68M | 609.84M | 542.19M |
| Liabilities (USD) | 3.74B | 3.37B | 3.51B | 3.47B | 3.16B | 2.53B | 2.37B | 2.03B | 2.00B | 1.73B | 1.44B | 1.29B | 1.22B | 1.29B | 1.42B | 1.51B |
| Other Non-current Assets (USD) | 1.23B | 1.02B | 1.04B | 1.03B | 950.63M | 761.99M | 724.78M | 638.15M | 648.09M | 539.23M | 523.19M | 535.43M | 724.39M | 783.06M | 774.60M | 669.32M |
| Intangible Assets (USD) | 278.91M | 257.14M | 285.43M | 306.05M | 307.45M | 196.79M | 206.24M | 217.31M | 226.72M | 167.06M | 115.25M | 112.78M | - | - | - | 104.37M |
| Fixed Assets (USD) | 845.64M | 770.28M | 803.37M | 778.60M | 799.37M | 798.87M | 748.66M | 717.53M | 668.27M | 563.71M | 517.23M | 511.46M | 514.44M | 469.42M | 410.01M | 364.47M |
| Noncurrent Assets (USD) | 2.35B | 2.05B | 2.13B | 2.12B | 2.06B | 1.76B | 1.68B | 1.57B | 1.54B | 1.27B | 1.16B | 1.16B | 1.24B | 1.25B | 1.18B | 1.14B |
| Other Current Assets (USD) | 975.44M | 851.63M | 844.34M | 933.40M | 854.82M | 759.29M | 835.36M | 777.04M | 751.33M | 674.74M | 648.43M | 644.90M | 703.57M | 665.98M | 777.44M | 927.79M |
| Inventory (USD) | 387.23M | 342.27M | 385.87M | 441.69M | 414.54M | 297.61M | 274.29M | 268.82M | 255.39M | 222.05M | 214.38M | 204.53M | 210.41M | 198.94M | 241.42M | 217.10M |
| Current Assets (USD) | 1.36B | 1.19B | 1.23B | 1.38B | 1.27B | 1.06B | 1.11B | 1.05B | 1.01B | 896.78M | 862.82M | 849.43M | 913.99M | 864.92M | 1.02B | 1.14B |
| Assets (USD) | 3.71B | 3.24B | 3.36B | 3.49B | 3.33B | 2.81B | 2.79B | 2.62B | 2.55B | 2.17B | 2.02B | 2.01B | 2.15B | 2.12B | 2.20B | 2.28B |
News and Insights
The global pharmaceutical metal detector market is projected to grow from USD 162.17 billion in 2024 to USD 270.93 billion by 2034, with a 5.28% CAGR, driven by rising demand for contamination-free products and technological advancements in metal detection systems.
The Indoor Air Quality Monitor Market is expected to grow from $5.03 billion in 2023 to $9.38 billion by 2032, driven by rising indoor pollution, regulatory push, consumer health awareness, smart home integrations, and advanced sensor technology.
The Raman Spectroscopy market is expected to grow significantly due to the increasing demand for precise molecular analysis in various industries, driven by advancements in laser and sensor technologies. The market is expected to reach USD 2.00 billion by 2032, growing at a CAGR of 7.51% from 2024 to 2032.
The global single-use bioprocessing probes and sensors market is expected to grow at a CAGR of 11.36% from 2023 to 2034, driven by advancements in bioprocessing technologies, rising biologics demand, and increased adoption of disposable bioprocessing systems.
The global food processing equipment market is expected to grow at a CAGR of 5.85% from 2024 to 2031, driven by rising demand for processed foods, technological advancements, and sustainability trends.
The global sample preparation market is expected to grow at a CAGR of 6.4% by 2031, driven by technological advancements in specimen collection and preparation. The consumables segment and solid-phase extraction technique are expected to lead the market growth.
The article discusses the potential impact of President Trump's policies on the stock market in 2025, noting that while a corporate tax rate cut could boost earnings, the growing deficit may make further tax cuts difficult. The author suggests the stock market's performance may not match the economic growth under the Trump administration.
The global viral inactivation market is expected to grow from $653.8 million in 2023 to $1915.2 million by 2033, driven by increased investments in the life sciences industry and the need for better biopharmaceutical treatments. However, challenges related to the inactivation process may impede market growth.
Global Washdown Scales Market Size To Exceed USD 9.12 Billion By 2033 | CAGR Of 5.7% - GlobeNewswirepositive
The global washdown scales market is expected to grow from USD 5.24 billion in 2023 to USD 9.12 billion by 2033, driven by the increasing demand in industries like food, pharmaceutical, and chemical. The portable and pharmaceutical industry segments are expected to lead the market growth.